Long-term benzodiazepine use, evidence for discontinuation strategies

The Canadian Agency for Drugs and Technology in Health (CADTH) has published a review that  aims to summarize current evidence-based discontinuation strategies and clinical guidelines for long-term adult BZD users to validate policy changes and promote best practices amongst clinicians.

The review is available by clicking here